Table 1.
Data collected before the withdrawal of life-sustaining therapies (baseline) and during thoraco-abdominal normothermic regional perfusion
| Baseline | TA-NRP | |||||
|---|---|---|---|---|---|---|
| 1′ | 15′ | 30′ | 60′ | 90′ | ||
| ECMO flow (L/min) | 0 | 3 | 0 | 1 | 1 | 1 |
| Cardiac index (L/min/m2)a | 3.9 | 3.7 | 3.2 | 3.7 | 3.7 | 3.7 |
| LVEF (%) | 74 | 54 | ||||
| SpO2 (%) | 97 | 100 | 89 | 100 | 100 | 100 |
| paO2 (mmHg) | 91.8 | 423 | 62 | 486 | 455 | 383 |
| paCO2 (mmHg) | 48.8 | 55.5 | 57.2 | 25.8 | 22.8 | 24.0 |
| pH | 7.37 | 7.09 | 7.16 | 7.44 | 7.49 | 7.46 |
| HCO3− (mEq/L) | 28.4 | 17.2 | 20.5 | 17.8 | 17.7 | 17.3 |
| Lactate | 0.7 | 8.4 | 4.8 | 4.2 | 3.8 | 3.6 |
| Hematocrit (%) | 34.5 | 38.4 | 29.3 | 29.7 | 29.9 | 26.6 |
| Hemoglobin (g/dL) | 11.3 | 12.6 | 9.5 | 9.7 | 9.8 | 8.7 |
| Troponin I (μg/dl) | 0.13 | 1.91 | 1.51 | 1.91 | 2.18 | 2.12 |
| ALT (IU/L) | 21 | 21 | 20 | 93 | 138 | |
| AST (IU/L) | 24 | 35 | 33 | 130 | 181 | |
| Bilirubin (mg/dL) | 0.5 | 0.4 | 0.3 | 0.5 | 0.4 | |
LVEF Left Ventricular Ejection Fraction measured by echocardiography, TA-NRP Thoraco-Abdominal Normothermic Regional Perfusion
aCalculated by Swan-Ganz monitoring